The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Immunodeficiency and Chronic Myelogenous Leukemia-like Syndrome in Mice with a Targeted Mutation of the ICSBP Gene
Open accessAbstract
Interferon consensus sequence binding protein (ICSBP) is a transcription factor of the interferon (IFN) regulatory factor (IRF) family. Mice with a null mutation of ICSBP exhibit two prominent phenotypes related to previously described activities of the IRF family. The first is enhanced susceptibility to virus infections associated with impaired production of IFN(gamma). The second is deregulated hematopoiesis in both ICSBP-/- and ICSBP+/- mice that manifests as a syndrome similar to human chronic myelogenous leukemia. The chronic period of the disease progresses to a fatal blast crisis characterized by a clonal expansion of undifferentiated cells. Normal mice injected with cells from mice in blast crisis developed acute leukemia within 6 weeks of transfer. These results suggest a novel role for ICSBP in regulating the proliferation and differentiation of hematopoietic progenitor cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NF1 deficiency in myeloid progenitor cells results in cytokine hypersensitivity and myeloproliferation.”
In the citing paper
“and myeloid cells from these mice are hypersensitive to the same cytokines as Nf1-deficient cells (4,13,14).”
In the citing paper
“ICSBP/ IRF8 deficiency induces myeloproliferation in mice”
In the citing paper
“ICSBP 2 / 2 mice are immunodeficient and susceptible to various pathogens.”
From Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells (2002) · cites this paper as [37]
In the citing paper
“The phenotype of ICSBP 2 / 2 mice suggested a previously unpredicted role of ICSBP in myeloid cell development. (37)”
From Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells (2002) · cites this paper as [37]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Hsu, S. M., Raine, L., & Fanger, H. (1981) · Journal of Histochemistry & Cytochemistry · doi:10.1177/29.4.6166661 · Cited by 14,140
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
Self-citationTrinchieri, G. (1995) · Annual Review of Immunology · doi:10.1146/annurev.iy.13.040195.001343 · Cited by 2,399
Immune Response in Mice that Lack the Interferon-γ Receptor
Huang, S., Hendriks, W., Althage, A., Hemmi, S., Bluethmann, H., Kamijo, R., Vilček, J., Zinkernagel, R. M., & Aguet, M. (1993) · Science · doi:10.1126/science.8456301 · Cited by 1,548
Self-citationChromosomal translocations in human cancer
Rabbitts, T. H. (1994) · Nature · doi:10.1038/372143a0 · Cited by 1,503
Moskophidis, D., Lechner, F., Pircher, H., & Zinkernagel, R. M. (1993) · Nature · doi:10.1038/362758a0 · Cited by 1,240
Self-citationMetcalf, D. (1989) · Nature · doi:10.1038/339027a0 · Cited by 1,023
Rudnicki, M. A., Braun, T., Hinuma, S., & Jaenisch, R. (1992) · Cell · doi:10.1016/0092-8674(92)90508-a · Cited by 985
Miyamoto, M., Fujita, T., Kimura, Y., Maruyama, M., Harada, H., Sudo, Y., Miyata, T., & Taniguchi, T. (1988) · Cell · doi:10.1016/s0092-8674(88)91307-4 · Cited by 978
Research works printed but not linked: 2
- Maniatis, T., Whittemore, L., Du, W., Fan, C., Keller, A.D., Palombella, V.J., and Thanos, D.N. (1992). Positive and negative control of interferon-β gene expression. In Transcription Regulation, S.L. McKnight and K.R. Yamamoto, eds. (Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press), pp. 1193–1220.
- Zinkernagel, 1986, T cell mediated hepatitis in mice infected with lymphocytic choriomeningitis virus, J. Exp. Med., 164, 1057
Cited by
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
CELLULAR RESPONSES TO INTERFERON-γ
Boehm, U., Klamp, T., Groot, M., & Howard, J. C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.749 · Cited by 2,890
Merad, M., Sathe, P., Helft, J., Miller, J., & Mortha, A. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074950 · Cited by 2,309
“Irf8−/− animals develop a myeloproliferative disease distinguished by excessive granulocyte production; failure to generate adequate monocyte numbers (128); and lack of pDCs, spleen-resident CD8+ cDCs, and nonlymphoid tissue CD103+ cDCs (Figure 4) (33, 129–132).”
BackgroundTranscriptional regulation of macrophage polarization: enabling diversity with identity
Lawrence, T., & Natoli, G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3088 · Cited by 2,284
“Such transcription factors include those that are known to be relevant for macrophage differentiation, such as IFN regulatory factor 8 (IRF8”
BackgroundHonda, K., & Taniguchi, T. (2006) · Nature Reviews Immunology · doi:10.1038/nri1900 · Cited by 1,676
Metadata
- Authors
- Holtschke, T., Löhler, J., Kanno, Y., Fehr, T., Giese, N., Rosenbauer, F., Lou, J., Knobeloch, K.-P., Gabriele, L., Waring, J. F., Bachmann, M. F., Zinkernagel, R. M., Morse, H. C., Ozato, K., & Horak, I.
- Affiliations
- University of Würzburg (DE)
- Universität Hamburg (DE)
- National Institutes of Health (US)
- University of Zurich (CH)
- Corresponding author
- Horak, Ivan
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1996-10
- Volume
- 87
- Issue
- 2
- Pages
- 307-317
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2008228521
- Cited by
- 644
- References
- 39
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 15 · 2023: 13 · 2022: 15 · 2021: 21 · 2020: 22 · 2019: 19 · 2018: 17 · 2017: 23 · 2016: 31 · 2015: 23 · 2014: 32 · 2013: 34 · 2012: 27
- FWCI
- 7.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 6133 d)
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Health Sciences › Medicine › Hematology › Chronic Myeloid Leukemia Treatments
- Keywords
- IRF8, immunodeficiency, interferon-gamma, viral susceptibility, blast crisis, acute leukemia, hematopoietic progenitor cells, clonal expansion, knockout mice
- MeSH terms
- Interferon Regulatory Factor-8, Animals, Blast Crisis, Carrier Proteins, Cytotoxicity, Immunologic, Gene Expression Regulation, Hematopoiesis, Immunity, Cellular, Immunologic Deficiency Syndromes, Interferons, Leukemia, Experimental, Neoplasm Transplantation, Repressor Proteins, Syndrome, Transcription Factors, Virus Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Interferon-alpha, Interferon-beta, Mice, Knockout, Interferon Regulatory Factors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Immunodeficiency and Chronic Myelogenous Leukemia-like Syndrome in Mice with a Targeted Mutation of the ICSBP Gene. https://app.cochat.ai/papers/10.1016/s0092-8674(00)81348-3
- The paper
- Holtschke, T., Löhler, J., Kanno, Y., Fehr, T., Giese, N., Rosenbauer, F., Lou, J., Knobeloch, K.-P., Gabriele, L., Waring, J. F., Bachmann, M. F., Zinkernagel, R. M., Morse, H. C., Ozato, K., & Horak, I. (1996). Immunodeficiency and Chronic Myelogenous Leukemia-like Syndrome in Mice with a Targeted Mutation of the ICSBP Gene. Cell. https://doi.org/10.1016/s0092-8674(00)81348-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.